Medical Properties Trust, Inc.

Valuation Analysis

About the Company

Medical Properties Trust, Inc. en bref

Medical Properties Trust, Inc. (MPT) is currently trading at 3,96 € with a market capitalization of 2,4 Md €. The 52-week range spans from 3,47 € to 5,68 €; the current price is 30.3% below the yearly high. Year-over-year revenue growth stands at +12.6%.

💰 Dividende

Medical Properties Trust, Inc. pays an annual dividend of 0,32 € per share, representing a yield of 7.98%. The payout ratio stands at 1054.55%. The elevated payout ratio reflects a mature dividend policy.

📊 Avis des analystes

7 analystes évaluent Medical Properties Trust, Inc. (MPT) au consensus : Conserver. L'objectif de cours moyen est de 5,02 €, soit un potentiel de +26.7% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 3,95 € à 7,03 €.

Medical Properties Trust, Inc. : la thèse d'investissement en détail

Medical Properties Trust, Inc. (MPT) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 12.6% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 95.96%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. The debt-to-equity ratio of 212.56% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn. Short interest sits at 29.79% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 26.7% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to market-like volatility, elevated short interest (29.79%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Medical Properties Trust, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.